Friday, June 9, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Medicine & Health

With antibiotic resistance, ‘we are running out of options’

November 23, 2021
in Medicine & Health
0
Share on FacebookShare on Twitter

Experts predict that without intervention, the problem of multidrug-resistant bacterial infections could be catastrophic by 2050, killing nearly 10 million people each year.

Hannah Bovermann, left, and Joseph Boll.

Credit: UTA/Randy Gentry

Experts predict that without intervention, the problem of multidrug-resistant bacterial infections could be catastrophic by 2050, killing nearly 10 million people each year.

To seek solutions, the National Institutes of Health awarded a five-year, $1.8 million grant to Joseph Boll, assistant professor of biology at The University of Texas at Arlington, to identify and inhibit the defense mechanisms of Acinetobacter baumannii, a pathogen that thrives in hospitals and clinical settings.

A. baumannii can cause infections in the blood, urinary tract and lungs, or in wounds in other parts of the body. Infections are generally treated with antibiotics, but many strains are resistant to medication, including carbapenems, a class of highly effective antibiotics usually reserved for severe multidrug-resistant bacterial infections.

“In previous research, we discovered that when A. baumannii experiences stress, such as antibiotic treatment, it modifies its cell envelope to tolerate the antibiotic for extended periods of time,” Boll said. “Specific modifications allow the bacteria to survive long enough to acquire true antibiotic resistance, which can lead to antibiotic treatment failure. This can happen within 24 hours of antibiotic exposure.”

Boll’s team expects to identify what adaptations in the cell envelope allow the pathogen to survive in the presence of antibiotics and how survival contributes to the acquisition of true resistance.

In a recent study titled “Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharaide-Deficient Acinetobacter baumannii,” which was published in the journal mBio, the team showed that two LD-transpeptidase enzymes remodel A. baumannii’s cell envelope to promote its survival when under stress, such as the kind experienced during antibiotic treatment.

Armed with this breakthrough, Hannah Bovermann, a senior double-major in biology and microbiology, is dissecting the genes that encode the bacteria’s LD-transpeptidases to learn what stress conditions induce their activation. She isolates the LD-transpeptidase promoters, the part of the DNA that controls when other parts of DNA are used, and glues it to a different gene whose function is to turn the bacterial cell blue. When the cell is in an environment where it wants to modify its cell envelope to protect itself, it turns blue, and Bovermann can observe the timing of the change.

To provoke this reaction, she administers antibiotics, experiments with various temperature changes, exposes the cell to pH gradients and subjects the cell to nutrient deprivations.

“Each response brings us closer to an understanding of how cell envelope modifications keep the bacterial cell intact in stress,” Bovermann said.

The researchers hope to find new targets on the cell surface for antibiotics to attack, strengthening existing medications’ potency against A. baumannii infections.

Drug-resistant bacteria have cornered health care providers into using combinatorial therapies, where multiple drugs are employed to treat bacterial infections, but even those methods are becoming increasingly ineffective, Boll said.

“It has become a game. Researchers discover a new antimicrobial, then bacteria become resistant to it. We are running out of options,” Boll said. “Bacterial resistance is quickly outpacing new antibiotic development.”



Tags: antibioticoptionsresistancerunning
Share26Tweet16Share5ShareSendShare
  • Schrödinger’s cat code

    Schrödinger’s cat makes better qubits

    65 shares
    Share 26 Tweet 16
  • The problems with coal ash start smaller than anyone thought

    66 shares
    Share 26 Tweet 17
  • ‘Revolutionary’ research discovers new cause of cancer coming from inside us

    65 shares
    Share 26 Tweet 16
  • Birmingham spinout to develop 20-minute test following surge in sexually transmitted infections

    64 shares
    Share 26 Tweet 16
  • Taurine may be a key to longer and healthier life

    64 shares
    Share 26 Tweet 16
  • Nearly 70% of private label avocado oil rancid or mixed with other oils

    67 shares
    Share 27 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

UTHSC researchers’ work on human pangenome aids understanding of common chromosomal abnormality

Null results research now published by major behavioral medicine journal

Multiple sclerosis more prevalent in Black Americans than previously thought

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 206 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In